Seres Therapeutics Inc
(MCRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2014 | 03-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -4,366 | -1,689 | -6,100 | -3,120 |
| Depreciation Amortization | 66 | 30 | 80 | 20 |
| Accounts payable and accrued liabilities | 124 | 99 | N/A | N/A |
| Other Working Capital | 369 | 195 | 450 | 140 |
| Other Operating Activity | 308 | -58 | 250 | 40 |
| Operating Cash Flow | $-3,499 | $-1,423 | $-5,320 | $-2,920 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -312 | -80 | -170 | -290 |
| Other Investing Activity | -102 | 0 | -10 | -20 |
| Investing Cash Flow | $-414 | $-80 | $-180 | $-310 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 1,500 | 500 | N/A | N/A |
| Other Financing Activity | 10,558 | 0 | 940 | 9,430 |
| Financing Cash Flow | $12,058 | $500 | $940 | $9,430 |
| Beginning Cash Position | 1,654 | 1,654 | 6,210 | 20 |
| End Cash Position | 9,799 | 651 | 1,650 | 6,210 |
| Net Cash Flow | $8,145 | $-1,003 | $-4,560 | $6,190 |
| Free Cash Flow | ||||
| Operating Cash Flow | -3,499 | -1,423 | -5,320 | -2,920 |
| Capital Expenditure | -312 | -80 | N/A | N/A |
| Free Cash Flow | -3,811 | -1,503 | -5,320 | -2,920 |